ARCLK vs ONCSM Comparison
Price, market cap, valuation, profitability and leverage metrics of ARCLK and ONCSM side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ARCLK | ONCSM | Sector median |
|---|---|---|---|
| Last price (TL) | 84.10 | 82.50 | 20.13 |
| Daily change | −1.98% | −7.41% | −6.06% |
| Market cap | TRY 56.8B | TRY 2B | TRY 3.7B |
| P/E | — | 26.70 | 15.42 |
| P/B | 0.75 | 4.21 | 1.08 |
| Dividend yield | 1.71% | — | 1.50% |
| Return on equity | −4.06% | 18.26% | −4.60% |
| Free float | 17.46% | 40.86% | 34.94% |
Popular Comparisons
Related Pages
About the ARCLK vs ONCSM Comparison
Price, market cap, valuation multiples, profitability and leverage of ARCLK (Arçelik) and ONCSM (Oncosem Onkolojik Sistemler) side by side as of Sep 28, 2026, 15:02. Of the 15 metrics compared, ARCLK leads in 4 and ONCSM leads in 11.
Highlights: Daily change: ARCLK leads (−1.98% vs −7.41%). Market cap: ARCLK leads (TRY 56.8B vs TRY 2B). P/B: ARCLK leads (0.75 vs 4.21). EV/EBITDA: ONCSM leads (7.50 vs 9.31). EV/Sales: ARCLK leads (0.90 vs 4.76). Gross margin: ONCSM leads (54.30% vs 29.57%). EBITDA margin (annual): ONCSM leads (41.91% vs 14.15%). Net margin (annual): ONCSM leads (10.83% vs −0.60%).
Frequently Asked Questions
Is ARCLK or ONCSM cheaper?
By P/E, Tie is cheaper (— vs 26.70); by P/B, ARCLK trades at the lower multiple (0.75 vs 4.21).
Which is more profitable, ARCLK or ONCSM?
Annual net margin is −0.60% for ARCLK and 10.83% for ONCSM; return on equity is −4.06% for ARCLK and 18.26% for ONCSM.
Which is more leveraged, ARCLK or ONCSM?
The leverage ratio is 86.30 for ARCLK and 44.59 for ONCSM; net debt/EBITDA is 2.78 for ARCLK and 0.48 for ONCSM. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.